Trial intelligence / Profile preview

Nitroglycerine vs Dexmedetomidine for Blood Pressure Control During Spine Surgery

NCT07901023Completed

Sponsor
Mayo Clinic
Start
Jan 2026
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised trial of dexmedetomidine (2 arms), sponsored by Mayo Clinic. Primary endpoint: Mean Arterial Pressure at 5 months. Started Jan 2026; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on NCT07901023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07901023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call